Literature DB >> 27873192

On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance Database.

Jonathan S Schildcrout1,2, Joshua C Denny3,4, Dan M Roden3,4,5.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 27873192      PMCID: PMC5225656          DOI: 10.1007/s40264-016-0476-z

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  7 in total

1.  Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients.

Authors:  Grace Juyun Kim; Soo Youn Lee; Ji Hye Park; Brian Y Ryu; Ju Han Kim
Journal:  Drug Saf       Date:  2017-01       Impact factor: 5.606

Review 2.  Global implementation of genomic medicine: We are not alone.

Authors:  Teri A Manolio; Marc Abramowicz; Fahd Al-Mulla; Warwick Anderson; Rudi Balling; Adam C Berger; Steven Bleyl; Aravinda Chakravarti; Wasun Chantratita; Rex L Chisholm; Vajira H W Dissanayake; Michael Dunn; Victor J Dzau; Bok-Ghee Han; Tim Hubbard; Anne Kolbe; Bruce Korf; Michiaki Kubo; Paul Lasko; Erkki Leego; Surakameth Mahasirimongkol; Partha P Majumdar; Gert Matthijs; Howard L McLeod; Andres Metspalu; Pierre Meulien; Satoru Miyano; Yaakov Naparstek; P Pearl O'Rourke; George P Patrinos; Heidi L Rehm; Mary V Relling; Gad Rennert; Laura Lyman Rodriguez; Dan M Roden; Alan R Shuldiner; Sukdeb Sinha; Patrick Tan; Mats Ulfendahl; Robyn Ward; Marc S Williams; John E L Wong; Eric D Green; Geoffrey S Ginsburg
Journal:  Sci Transl Med       Date:  2015-06-03       Impact factor: 17.956

3.  Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.

Authors:  J S Schildcrout; J C Denny; E Bowton; W Gregg; J M Pulley; M A Basford; J D Cowan; H Xu; A H Ramirez; D C Crawford; M D Ritchie; J F Peterson; D R Masys; R A Wilke; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

4.  A prognostic model based on readily available clinical data enriched a pre-emptive pharmacogenetic testing program.

Authors:  Jonathan S Schildcrout; Yaping Shi; Ioana Danciu; Erica Bowton; Julie R Field; Jill M Pulley; Melissa A Basford; William Gregg; James D Cowan; Frank E Harrell; Dan M Roden; Josh F Peterson; Joshua C Denny
Journal:  J Clin Epidemiol       Date:  2015-11-25       Impact factor: 6.437

5.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

Authors:  A R Shuldiner; M V Relling; J F Peterson; J K Hicks; R R Freimuth; W Sadee; N L Pereira; D M Roden; J A Johnson; T E Klein; Alan R Shuldiner; Mark Vesely; Shawn W Robinson; Nicholas Ambulos; Sanford A Stass; Mark D Kelemen; Lawrence A Brown; Toni I Pollin; Amber L Beitelshees; Richard Y Zhao; Ruth E Pakyz; Kathleen Palmer; Tameka Alestock; Courtney O'Neill; Kristin Maloney; Amie Branham; Danielle Sewell; Mary V Relling; Kristine Crews; James Hoffman; Shane Cross; Cyrine Haidar; Don Baker; J Kevin Hicks; Gillian Bell; Fran Greeson; Aditya Gaur; Ulrike Reiss; Alicia Huettel; Cheng Cheng; Amar Gajjar; Alberto Pappo; Scott Howard; Melissa Hudson; Ching-Hon Pui; Sima Jeha; William E Evans; Ulrich Broeckel; Russ B Altman; Li Gong; Michelle Whirl-Carrillo; Teri E Klein; Wolfgang Sadee; Kandamurugu Manickam; Kevin M Sweet; Peter J Embi; Dan Roden; Josh Peterson; Josh Denny; Jonathan Schildcrout; Erica Bowton; Jill Pulley; Marc Beller; Jennifer Mitchell; Ioana Danciu; Lisa Price; Naveen L Pereira; Richard Weinshilboum; Liewei Wang; Julie A Johnson; David Nelson; Michael Clare-Salzler; Amanda Elsey; Benjamin Burkley; Taimour Langaee; Felix Liu; David Nessl; Hui-Jia Dong; Larry Lesko; Robert R Freimuth; Christopher G Chute
Journal:  Clin Pharmacol Ther       Date:  2013-03-19       Impact factor: 6.875

6.  Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.

Authors:  J M Pulley; J C Denny; J F Peterson; G R Bernard; C L Vnencak-Jones; A H Ramirez; J T Delaney; E Bowton; K Brothers; K Johnson; D C Crawford; J Schildcrout; D R Masys; H H Dilks; R A Wilke; E W Clayton; E Shultz; M Laposata; J McPherson; J N Jirjis; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-05-16       Impact factor: 6.875

7.  Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.

Authors:  S L Van Driest; Y Shi; E A Bowton; J S Schildcrout; J F Peterson; J Pulley; J C Denny; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2013-11-19       Impact factor: 6.875

  7 in total
  1 in total

1.  Clinical Utility of Pharmacogene Panel-Based Testing in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Nihal El Rouby; Adel Alrwisan; Taimour Langaee; Gloria Lipori; Dominick J Angiolillo; Francesco Franchi; Alberto Riva; Amanda Elsey; Julie A Johnson; Larisa H Cavallari; Almut G Winterstein
Journal:  Clin Transl Sci       Date:  2020-01-16       Impact factor: 4.689

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.